Swedish Orphan Biovitrum AB (publ) (BIOVF) News Today $29.99 0.00 (0.00%) As of 03/11/2025 Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Berenberg Bank Sticks to Its Buy Rating for Swedish Orphan Biovitrum AB (0MTD)February 18, 2025 | markets.businessinsider.comSwedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF) Sees Significant Decline in Short InterestSwedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF - Get Free Report) saw a large drop in short interest in January. As of January 31st, there was short interest totalling 642,400 shares, a drop of 55.7% from the January 15th total of 1,450,700 shares. Based on an average daily trading volume, of 100 shares, the days-to-cover ratio is currently 6,424.0 days.February 14, 2025 | marketbeat.comKepler Capital Keeps Their Hold Rating on Swedish Orphan Biovitrum AB (0MTD)February 8, 2025 | markets.businessinsider.comRBC Capital Reaffirms Their Buy Rating on Swedish Orphan Biovitrum AB (0MTD)February 6, 2025 | markets.businessinsider.comSwedish Orphan Biovitrum targets high single-digit growth in 2025 amid robust pipeline advancementsFebruary 6, 2025 | msn.comSwedish Orphan Biovitrum AB (publ) (BIOVF) Q4 2024 Earnings Call TranscriptFebruary 5, 2025 | seekingalpha.comSobi publishes Q4 2024 report: A solid ending to a strong yearFebruary 5, 2025 | finance.yahoo.comSwedish Orphan Biovitrum shares dip on Q4 earningsFebruary 5, 2025 | msn.comSwedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF) Short Interest UpdateSwedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF - Get Free Report) saw a large decline in short interest in the month of January. As of January 15th, there was short interest totalling 1,377,300 shares, a decline of 7.8% from the December 31st total of 1,494,600 shares. Based on an average daily trading volume, of 100 shares, the days-to-cover ratio is presently 13,773.0 days.February 2, 2025 | marketbeat.comSwedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF) Short Interest Down 7.8% in DecemberSwedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF - Get Free Report) was the recipient of a large decline in short interest in December. As of December 31st, there was short interest totalling 1,377,300 shares, a decline of 7.8% from the December 15th total of 1,494,600 shares. Based on an average daily volume of 100 shares, the days-to-cover ratio is presently 13,773.0 days.January 18, 2025 | marketbeat.comBerenberg Bank Sticks to Their Buy Rating for Swedish Orphan Biovitrum AB (0MTD)January 14, 2025 | markets.businessinsider.comSwedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF) Upgraded by Barclays to "Strong-Buy" RatingBarclays upgraded shares of Swedish Orphan Biovitrum AB (publ) to a "strong-buy" rating in a research note on Wednesday.January 9, 2025 | marketbeat.comNotice of Extraordinary General Meeting in Swedish Orphan Biovitrum AB (publ)November 11, 2024 | prnewswire.comDavid Meek is proposed as new Chair of the Board of Directors of SobiNovember 5, 2024 | finance.yahoo.comKepler Capital Sticks to Their Hold Rating for Swedish Orphan Biovitrum AB (0MTD)October 29, 2024 | markets.businessinsider.comSwedish Orphan Biovitrum Q3 Results Climb, Lifts FY24 Revenue View; Stock RisesOctober 24, 2024 | markets.businessinsider.comSwedish Orphan Biovitrum (OTC:BIOVF) Stock, Short Interest ReportOctober 15, 2024 | benzinga.comKepler Capital downgrades Swedish Orphan Biovitrum AB (0MTD) to a HoldSeptember 21, 2024 | markets.businessinsider.comShort Interest in Swedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF) Decreases By 9.6%Swedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF - Get Free Report) saw a significant decline in short interest during the month of August. As of August 31st, there was short interest totalling 1,107,000 shares, a decline of 9.6% from the August 15th total of 1,224,400 shares. Based on an average trading volume of 100 shares, the days-to-cover ratio is currently 11,070.0 days.September 17, 2024 | marketbeat.comSwedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF) Hits New 12-Month High at $31.28Swedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF) Hits New 12-Month High at $31.28September 10, 2024 | marketbeat.comSwedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF) Reaches New 12-Month High at $30.55Swedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF) Sets New 52-Week High at $30.55August 29, 2024 | marketbeat.comMirum Pharma gains amid report of approach from Swedish Orphan BiovitrumJuly 26, 2024 | msn.comSwedish Orphan Biovitrum AB (publ) (BIOVF)July 22, 2024 | uk.finance.yahoo.comSwedish Orphan Biovitrum AB (0MTD) Receives a Buy from RBC CapitalJuly 19, 2024 | markets.businessinsider.comSwedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF) Stock Price Down 1.7%Swedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF) Trading Down 1.7%July 3, 2024 | marketbeat.comSobi Receives US FDA Fast Track Designation for Emapalumab-lzsg being investigated in Macrophage Activation SyndromeMay 24, 2024 | finance.yahoo.comSobi to present new myelofibrosis data at the ASCO 2024 Annual MeetingMay 24, 2024 | finance.yahoo.comSobi has completed SEK 3 billion senior bond issueMay 8, 2024 | finance.yahoo.comSwedish Orphan Biovitrum AB (publ) (SOBI.ST)May 6, 2024 | uk.finance.yahoo.comSwedish Orphan Biovitrum AB (publ) (BIOVF) Q1 2024 Earnings Call TranscriptApril 27, 2024 | seekingalpha.comSobi® receives positive CHMP opinion recommending approval of efanesoctocog alfa for once-weekly treatment of haemophilia AApril 26, 2024 | finance.yahoo.comSwedish Orphan Biovitrum AB reports Q1 resultsApril 25, 2024 | msn.comSobi Q1 2024 report: Strong sales reflecting the strength of the portfolioApril 25, 2024 | finance.yahoo.comSwedish Orphan Biovitrum AB earnings: here's what to expectApril 24, 2024 | markets.businessinsider.comNotice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ)April 4, 2024 | prnewswire.comSobi publishes Annual and sustainability report for 2023April 2, 2024 | finance.yahoo.comSwedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF) Sets New 52-Week High at $27.79Swedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF) Reaches New 12-Month High at $27.79March 12, 2024 | marketbeat.comSwedish Orphan Biovitrum AB (publ) (SWOBY)February 20, 2024 | au.finance.yahoo.comSobi publishes Q4 2023 report: Strong revenue performance and growth into 2024February 8, 2024 | finance.yahoo.comSwedish Orphan Biovitrum price target raised to SEK 385 at RBC CapitalFebruary 3, 2024 | realmoney.thestreet.comAll You Need to Know About Swedish Orphan Biovitrum (BIOVF) Rating Upgrade to Strong BuyFebruary 1, 2024 | finance.yahoo.comInvitation: Sobi's Q4 and FY 2023 reportJanuary 24, 2024 | finance.yahoo.comSobi's Chairman of the Board resigns due to health reasonsJanuary 5, 2024 | finance.yahoo.comChange in number of shares and votes in Swedish Orphan Biovitrum AB (publ)November 30, 2023 | finance.yahoo.comSwedish Orphan Biovitrum AB BIOVFNovember 23, 2023 | morningstar.comSobi has completed the issuances of series C sharesNovember 1, 2023 | finance.yahoo.comSwedish Orphan Biovitrum AB Non-GAAP EPS of SEK0.54, revenue of SEK5.17BOctober 30, 2023 | msn.comSwedish Orphan Biovitrum (BIOVF) Q3 Earnings Miss EstimatesOctober 30, 2023 | finance.yahoo.comSobi publishes Q3 2023 report: Strong revenue and solid performanceOctober 30, 2023 | finance.yahoo.comReminder: Invitation: Sobi's Q3 2023 reportOctober 27, 2023 | finance.yahoo.com Remove Ads Get Swedish Orphan Biovitrum AB (publ) News Delivered to You Automatically Sign up to receive the latest news and ratings for BIOVF and its competitors with MarketBeat's FREE daily newsletter. Email Address BIOVF Media Mentions By Week BIOVF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIOVF News Sentiment▼0.000.82▲Average Medical News Sentiment BIOVF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIOVF Articles This Week▼00▲BIOVF Articles Average Week Remove Ads Get Swedish Orphan Biovitrum AB (publ) News Delivered to You Automatically Sign up to receive the latest news and ratings for BIOVF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Edwards Lifesciences News Today UCB News Today GE HealthCare Technologies News Today UCB News Today argenx News Today IDEXX Laboratories News Today Veeva Systems News Today Agilent Technologies News Today ResMed News Today IQVIA News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:BIOVF) was last updated on 3/12/2025 by MarketBeat.com Staff From Our PartnersDeFi Coin on Verge of Breakout!We’re Opening the Ultimate Crypto Vault… Don't let this be the missed opportunity you regret for years. Crypto 101 Media | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredDOGE’s Next Move: Not what you thinkDonald Trump, Elon Musk and the Department of Government Efficiency have kept their word. Moving even faste...Weiss Ratings | SponsoredYour Wealth is Under AttackHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Swedish Orphan Biovitrum AB (publ) Please log in to your account or sign up in order to add this asset to your watchlist. Share Swedish Orphan Biovitrum AB (publ) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BIOVF Stock Alerts